ambroxol has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bomba-Opoń, DA | 1 |
| Wiczyńska-Zajac, A | 1 |
| Domańska-Janczewska, E | 1 |
| Kociszewska-Najman, B | 1 |
| Marianowski, L | 1 |
1 other study available for ambroxol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
[The effectiveness of prenatal steroid and ambroxol therapy for the prevention of respiratory distress syndrome in newborns of diabetic mothers].
Topics: Adult; Ambroxol; Anti-Inflammatory Agents; Diabetes Mellitus, Type 1; Expectorants; Female; Humans; | 2000 |